Laurie Stelzer - 22 Nov 2023 Form 3 Insider Report for Spyre Therapeutics, Inc. (SYRE)

Role
Director
Signature
/s/ Heidy King-Jones, as Attorney-in-Fact
Issuer symbol
SYRE
Transactions as of
22 Nov 2023
Net transactions value
$0
Form type
3
Filing time
27 Nov 2023, 16:27:52 UTC
Previous filing
10 Aug 2023
Next filing
16 May 2024

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney